Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future

Timothy M Robinson; Carlo Palmieri; Jeremy Braybrooke

doi:10.1016/j.clon.2020.04.008

Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future

Timothy M Robinson
, Carlo Palmieri
, Jeremy Braybrooke

Research output: Contribution to journal › Editorial (Academic Journal) › peer-review

2 Citations (Scopus)

Original language	English
Journal	Clinical Oncology
Volume	32
Issue number	10
Early online date	14 May 2020
DOIs	https://doi.org/10.1016/j.clon.2020.04.008
Publication status	E-pub ahead of print - 14 May 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.clon.2020.04.008

Handle.net

Persistent link

Cite this

@article{c5ef9e57c667426ca8cd79bbfa1abd3f,

title = "Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future",

author = "Robinson, \{Timothy M\} and Carlo Palmieri and Jeremy Braybrooke",

year = "2020",

month = may,

day = "14",

doi = "10.1016/j.clon.2020.04.008",

language = "English",

volume = "32",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier Limited",

number = "10",

}

TY - JOUR

T1 - Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future

AU - Robinson, Timothy M

AU - Palmieri, Carlo

AU - Braybrooke, Jeremy

PY - 2020/5/14

Y1 - 2020/5/14

U2 - 10.1016/j.clon.2020.04.008

DO - 10.1016/j.clon.2020.04.008

M3 - Editorial (Academic Journal)

C2 - 32418676

SN - 0936-6555

VL - 32

JO - Clinical Oncology

JF - Clinical Oncology

IS - 10

ER -